NEW YORK (GenomeWeb News) – Verdezyne said that it will optimize selected genes that encode industrial enzymes for Novozymes, under a contract announced today.

Verdezyne, the Carlsbad, Calif.-based firm that was formerly called Coda Genomics, uses computational methods to design and synthesize gene libraries for engineering proteins, metabolic pathways, and microorganisms. Its technologies are used to optimize commercial fermentation processes, which are applied to manufacturing platform chemicals and biofuels.

Terms of the contract were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.